Cogent Biosciences所有資訊

Cogent Biosciences | ARS：年度報告

04/24 04:41

Cogent Biosciences | DEFA14A：其他

04/24 04:38

Cogent Biosciences | DEF 14A：股東委託書決議

04/24 04:38

Cogent Biosciences | PRE 14A：並購重組委托聲明

04/13 04:36

Cogent Biosciences | EFFECT：其他

04/11 18:04

Cogent Biosciences | 4：持股變動聲明-董事 Ferrante Karen Jean

04/03 06:25

Cogent Biosciences | SC 13D/A：超過5%持股股東披露文件(修正)-Fairmount Funds Management LLC(9.90%),Fairmount Healthcare Fund II GP LLC(9.90%)等

04/02 06:33

Cogent Biosciences | 4：持股變動聲明-董事 Fairmount Funds Management LLC

04/02 06:23

Cogent Biosciences | S-3：特定交易註冊聲明

03/30 04:14

Cogent Biosciences | SC 13D/A：超過5%持股股東披露文件(修正)-Fairmount Funds Management LLC(9.90%),Fairmount Healthcare Fund II GP LLC(9.90%)等

03/28 04:41

Cogent Biosciences | 8-K：重大事件

03/22 20:36

Cogent Biosciences | S-8：員工福利計劃證券登記

02/27 05:37

Cogent Biosciences | 10-K：年度報表

02/26 22:15

Cogent Biosciences | 8-K：Cogent Biosciences報告了最近的業務亮點以及2023年第四季度和全年財務業績

02/26 21:35

Cogent Biosciences | SC 13D/A：超過5%持股股東披露文件(修正)-Fairmount Funds Management LLC(18.89%),Fairmount Healthcare Fund II GP LLC(15.99%)等

02/17 07:57

Cogent Biosciences | 4：持股變動聲明-股東 Fairmount Funds Management LLC

02/17 07:47

Cogent Biosciences | SC 13G/A：超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners II, L.P.(9.99%),VHCP Co-Investment Holdings II, LLC(9.99%)等

02/15 09:38

Cogent Biosciences | SC 13G/A：超過5%持股股東披露文件(修正)-Commodore Capital LP(7.1%),Commodore Capital Master LP(7.1%)

02/15 07:08

Cogent Biosciences | SC 13G/A：超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%)等

02/15 06:32

Cogent Biosciences | SC 13G/A：超過5%持股股東披露文件(修正)-Steven A. Cohen(6.1%),Point72 Asset Management, L.P.(6.0%)等

02/15 05:20